118 related articles for article (PubMed ID: 7059768)
21. [The value of breast lymphoscintigraphy in the definition of axillary staging in cancer of the breast].
Serin D; Vinot JM; Martin P; Reboul F; Robin M; Chevallier J
Bull Cancer; 1986; 73(3):299-304. PubMed ID: 3756366
[TBL] [Abstract][Full Text] [Related]
22. Pilot study comparing the accuracy of lymphoscintigraphy sentinel lymph node localisation with axillary node dissection in women with operable breast cancer.
Allen B; Campbell I; Desai S; Dray M; Scarlet J
N Z Med J; 2001 May; 114(1132):233-6. PubMed ID: 11453361
[TBL] [Abstract][Full Text] [Related]
23. Lymphoscintigraphy in staging and management of breast cancer.
Nisa L; Hussain F; Yasmin S; Afroj K
Bangladesh Med Res Counc Bull; 2000 Apr; 26(1):8-14. PubMed ID: 11192493
[TBL] [Abstract][Full Text] [Related]
24. Failure to detect drainage to the popliteal and epitrochlear lymph nodes on cutaneous lymphoscintigraphy in melanoma patients.
Uren RF; Howman-Giles RB; Thompson JF
J Nucl Med; 1998 Dec; 39(12):2195. PubMed ID: 9867173
[No Abstract] [Full Text] [Related]
25. Sentinel lymph node detection and imaging.
Uren RF; Thompson JF; Howman-Giles R; Roberts JM
Eur J Nucl Med; 1999 Aug; 26(8):936-8. PubMed ID: 10515713
[No Abstract] [Full Text] [Related]
26. A comparison of two technetium-99m-labeled radiopharmaceuticals for lymphoscintigraphy: concise communication.
Kaplan WD; Davis MA; Rose CM
J Nucl Med; 1979 Sep; 20(9):933-7. PubMed ID: 536838
[TBL] [Abstract][Full Text] [Related]
27. Optimization of axillary lymphoscintigraphy to detect the sentinel node in breast cancer.
De Cicco C; Cremonesi M; Chinol M; Bartolomei M; Pizzamiglio M; Leonardi L; Fiorenza M; Paganelli G
Tumori; 1997; 83(2):539-41. PubMed ID: 9226014
[No Abstract] [Full Text] [Related]
28. [The importance of lymphoscintigraphy in breast cancer].
Kanaev SV; Semiglazov VF; Bykov SA; Mironov EE; Zhdanova VI
Vopr Onkol; 1989; 35(11):1310-4. PubMed ID: 2609519
[TBL] [Abstract][Full Text] [Related]
29. Breast lymphoscintigraphy for sentinel node identification in breast cancers with clinically-negative axillary nodes.
Namwongprom S; Boonyaprapa S; Ekmahachai M; Vilasdechanon N; Somwangprasert A; Sumitsawan S; Taya P
Singapore Med J; 2005 Dec; 46(12):688-92. PubMed ID: 16308641
[TBL] [Abstract][Full Text] [Related]
30. Prediction of potential metastatic sites in cutaneous head and neck melanoma using lymphoscintigraphy.
O'Brien CJ; Uren RF; Thompson JF; Howman-Giles RB; Petersen-Schaefer K; Shaw HM; Quinn MJ; McCarthy WH
Am J Surg; 1995 Nov; 170(5):461-6. PubMed ID: 7485733
[TBL] [Abstract][Full Text] [Related]
31. Internal mammary lymphoscintigraphy in patients with breast cancer.
Lee S; Harolds JA
J Okla State Med Assoc; 1984 Feb; 77(2):43-7. PubMed ID: 6325648
[No Abstract] [Full Text] [Related]
32. Comparison of subareolar injection lymphoscintigraphy with the 1-day and the 2-day protocols for the detection of sentinel lymph nodes in patients with breast cancer.
Seok JW; Kim IJ; Heo YJ; Yang YJ; Choi YS; Kim BG; Park SJ
Ann Nucl Med; 2009 Jul; 23(5):465-9. PubMed ID: 19452250
[TBL] [Abstract][Full Text] [Related]
33. Imaging of regional spread of breast cancer by internal mammary lymphoscintigraphy, CT, and MRI.
Turoglu HT; Janjan NA; Thorsen MK; Shaffer KA; Ritch PS; Hansen RM; Walker AP; Gai M; Collier BD
Clin Nucl Med; 1992 Jun; 17(6):482-4. PubMed ID: 1617843
[TBL] [Abstract][Full Text] [Related]
34. Technical aspects of sentinel node lymphoscintigraphy for breast cancer.
Dunnwald LK; Mankoff DA; Byrd DR; Anderson BO; Moe RE; Yeung RS; Eary JF
J Nucl Med Technol; 1999 Jun; 27(2):106-11. PubMed ID: 10353106
[TBL] [Abstract][Full Text] [Related]
35. The application of internal mammary lymphoscintigraphy to planning of radiation therapy.
Dufresne EN; Kaplan WD; Zimmerman RE; Rose CM
J Nucl Med; 1980 Jul; 21(7):697-9. PubMed ID: 7391847
[TBL] [Abstract][Full Text] [Related]
36. Routine preoperative lymphoscintigraphy is not necessary prior to sentinel node biopsy for breast cancer.
Burak WE; Walker MJ; Yee LD; Kim JA; Saha S; Hinkle G; Olsen JO; Pozderac R; Farrar WB
Am J Surg; 1999 Jun; 177(6):445-9. PubMed ID: 10414690
[TBL] [Abstract][Full Text] [Related]
37. The relevance of internal mammary lymphoscintigraphy in the management of breast carcinoma.
Ege GN; Elhakim T
J Clin Oncol; 1984 Jul; 2(7):774-81. PubMed ID: 6737019
[TBL] [Abstract][Full Text] [Related]
38. The role of axillary lymphoscintigraphy in the diagnosis of breast cancer.
Boak JL; Ingoldby CJ; Nathan BE; Myers G
Clin Oncol; 1981 Mar; 7(1):45-52. PubMed ID: 7214763
[No Abstract] [Full Text] [Related]
39. [Peritumor interstitial double nuclide-double compound lymphoscintigraphy in the noninvasive detection of lymphatic metastases in tumors in the area of the face, skull and mouth cavities].
Jung H; Munz DL; Hör G; Frenkel G
Fortschr Kiefer Gesichtschir; 1985; 30():178-82. PubMed ID: 3861524
[No Abstract] [Full Text] [Related]
40. Internal mammary lymphoscintigraphy in patients with breast cancer. Correlation with computed tomography and impact on radiation therapy planning.
Collier BD; Palmer DW; Wilson JF; Greenberg M; Komaki R; Cox JD; Lawson TL; Lawlor PM
Radiology; 1983 Jun; 147(3):845-8. PubMed ID: 6844625
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
